MCK Stock Down Despite Latest Partnership to Boost SCD Treatment [Yahoo! Finance]
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
CRISPR Therapeutics Stock Falls 7% in Two Weeks: Time to Hold or Sell? [Yahoo! Finance]
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Could Be 48% Below Their Intrinsic Value Estimate [Yahoo! Finance]
SpyGlass Pharma Completes Enrollment in Phase I/II Study of its Promising Long-Term Drug Delivery Platform for Glaucoma and Ocular Hypertension [Yahoo! Finance]